<html>
<head>
  <title>SARS-CoV-2 RNA-dependent RNA polymerase member protein of the core replicase complex (a.k.a. NSP12) (RdRp) gene S759A literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="RdRp.html">RNA-dependent RNA polymerase member protein of the core replicase complex (a.k.a. NSP12) (RdRp)</a> gene <span class="constellation">RdRp:p.S759A</span> literature reference collection</h1>
<div class="effect_section"><h2 id="pharmaceutical_effectiveness">Pharmaceutical effectiveness</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> At genome position 15715 this nsp12 mutation had a GS-441524 P13 Lineage 3 amino acid change in 99.27% of populations of serially passaged SARS-CoV-2. GS-441524 P13 Lineage 1 amino acid change in 61.72% of the population tested and PP nsp12-S759A/V792I amino acid change in 99.72% of the population tested. This mutation had a 7x-9x fold decrease in sensitivity to RDV by EC50.<br/> (<a href="https://doi.org/10.1101/2022.01.25.477724" class="lit_link">Stevens et al. (2022)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
